- Home
- IMVT vs ARDT Comparison
IMVT vs ARDT Comparison
Compare IMVT & ARDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- ARDT
- Stock Information
- Founded
- IMVT N/A
- ARDT 2001
- Country
- IMVT United States
- ARDT United States
- Employees
- IMVT N/A
- ARDT N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- ARDT
- Sector
- IMVT Health Care
- ARDT
- Exchange
- IMVT Nasdaq
- ARDT NYSE
- Market Cap
- IMVT 2.5B
- ARDT 2.1B
- IPO Year
- IMVT N/A
- ARDT 2024
- Fundamental
- Price
- IMVT $14.85
- ARDT $14.46
- Analyst Decision
- IMVT Buy
- ARDT Buy
- Analyst Count
- IMVT 10
- ARDT 13
- Target Price
- IMVT $40.14
- ARDT $20.77
- AVG Volume (30 Days)
- IMVT 1.2M
- ARDT 309.7K
- Earning Date
- IMVT 05-29-2025
- ARDT 05-06-2025
- Dividend Yield
- IMVT N/A
- ARDT N/A
- EPS Growth
- IMVT N/A
- ARDT 935.52
- EPS
- IMVT N/A
- ARDT 1.64
- Revenue
- IMVT N/A
- ARDT $6,024,260,000.00
- Revenue This Year
- IMVT $108.88
- ARDT $8.18
- Revenue Next Year
- IMVT N/A
- ARDT $5.53
- P/E Ratio
- IMVT N/A
- ARDT $8.84
- Revenue Growth
- IMVT N/A
- ARDT 8.91
- 52 Week Low
- IMVT $12.72
- ARDT $11.31
- 52 Week High
- IMVT $34.47
- ARDT $20.72
- Technical
- Relative Strength Index (RSI)
- IMVT 50.48
- ARDT N/A
- Support Level
- IMVT $13.79
- ARDT N/A
- Resistance Level
- IMVT $15.22
- ARDT N/A
- Average True Range (ATR)
- IMVT 0.69
- ARDT 0.00
- MACD
- IMVT 0.13
- ARDT 0.00
- Stochastic Oscillator
- IMVT 78.24
- ARDT 0.00
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
About ARDT ARDENT HEALTH PARTNERS INC
Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services predominantly through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operate across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.